You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest FDA Articles
Popular FDA Articles
Highly Recommended FDA Articles
Send a link to this page to your friends and colleagues.
Can Januvia Trigger Cancer Symptoms?
I have been a type 2 diabetic for more than 10 years, and have been on Januvia for about half that time (previously Avandia). I recently read a Dr. Mercola piece where he said that Januvia may trigger some type of cancer symptoms because of how it impairs the bodies natural tumor fighting properties. I am 68 years old and this has me concerned. Has anyone heard about any legitimate studies on this? Thank you.
Januvia is an oral agent in a class of drugs known as incretin mimetics. It has been shown to reduce A1c a fraction of 1% in some mild type 2 diabetes. Thus its blood sugar effect is small compared to Glucophage, Actos, and Avandia. In theory it could cause nausea since one of its functions is to slow stomach emptying. In practice, however, nausea and other side effects are rare.
Perhaps the most serious adverse effect of this entire class of drugs is pancreatitis-inflammation of the pancreas. However, this is extremely rare and might affect one in 10-20,000 users. Since the pancreatitis reverses upon stopping the drug, one should be aware of its symptoms, which include severe pain in the upper abdomen radiating from back to front, nausea, loss of appetite, etc.
Like many supplements and prescription drugs, Januvia can interact with other drugs or supplements. Incretin mimetics have been shown to foster partial beta cell recovery in early diabetes, help prevent damage to kidneys caused by high blood sugar, and more recently possibly protect coronary arteries. Januvia is a pretty benign, but not a very effective, blood sugar drug.
There are sites on the Internet that inappropriately criticize this and many other medications approved by the FDA and propose instead supplements that may be ineffective or untested for toxicity.
Richard K. Bernstein, MD is one of the most knowledgeable, committed and successful pioneers in the field of diabetes today. He invented blood sugar self-monitoring and basal/bolus insulin dosing, when he was an engineer.
Dr. B is Director Emeritus of the Peripheral vascular Disease Clinic of the Albert Einstein College of Medicine. His private medical Practice in Mamaroneck N. Y. specializes in treating diabetes and obesity.
He is a physician, research scientist, thriving Type 1 for 67 years, and best-selling author of nine diabetes books including Diabetes Solution , The Diabetes Diet and several E-books. This link diabetes-book.com will give you more information about his publications. To sign up for his free monthly teleseminars, visit askdrbernstein.net.
1 comment - Jun 12, 2013
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.